ABC arbitrage

FY23 results in line with market conditions

Financials | 28/03/2024
Gym Group

The power of marginal gains

Travel & Leisure | 28/03/2024
Mendus

Regulatory green light for CADENCE trial

Pharmaceuticals & healthcare | 28/03/2024
Alpha Bank

Full steam ahead

Financials | 28/03/2024
Dalata Hotel

A strong hand

Travel & Leisure | 28/03/2024
S4 Capital

Extension of recovery horizon

Media | 28/03/2024
Datatec

FY24 revenue growth of 5.8%

Technology | 27/03/2024
AG Barr

Fizzing away

Consumer staples | 27/03/2024
Kolibri Global Energy

FY23 reserves show solid replacement rates

Oil & gas | 27/03/2024
Recce Pharmaceuticals

R&D advance (A$11.18m) extends runway

Pharmaceuticals & healthcare | 26/03/2024
Immix Biopharma

Marching towards US clinical trials for NXC-201

Pharmaceuticals & healthcare | 26/03/2024
Ocean Wilsons Holdings

Strong FY23 results with strategic review in FY24

Investment trusts | 25/03/2024
Kinepolis

On the move

Travel & Leisure | 25/03/2024
IRLAB Therapeutics

FDA thumbs up to mesdopetam’s Phase III plan

Pharmaceuticals & healthcare | 25/03/2024
Nano Dimension

Growth in a tough market

Technology | 25/03/2024
Northern Data Group

First transparency milestone achieved

Technology | 25/03/2024
Quadrise

Funding the gap to commercial revenues

General Industrials | 25/03/2024
Greencoat Renewables

Acquisitions generating more green

Alternative Energy | 25/03/2024
Henderson EuroTrust

Proposed merger with Henderson European Focus Trust

Investment trusts | 22/03/2024
HgT

Strong earnings growth and realisations in FY23

Investment trusts | 22/03/2024
Ascential

Clarity and focus on key platforms

Media | 22/03/2024
Vantiva

Termination of coverage

Technology | 22/03/2024
Orrön Energy

Capitalising on renewable ambitions

Alternative Energy | 22/03/2024
ReNeuron Group

Termination of coverage

Pharmaceuticals & healthcare | 22/03/2024
Respiri

Termination of coverage

Pharmaceuticals & healthcare | 22/03/2024
LXi REIT

Termination of coverage

Property | 22/03/2024
Round Hill Music Royalty Fund

Termination of coverage

Investment trusts | 22/03/2024
EQS Group

Termination of coverage

Media | 22/03/2024
ACWA Power

Record results for FY23

Industrial Support Services | 22/03/2024
Triple Point Social Housing REIT

Financial and operational progress

Property | 22/03/2024
Games Workshop Group

Steady as she goes

Consumer Support Services | 22/03/2024
Foxtons Group

Medium-term targets come into view

Property | 21/03/2024
Dowlais Group

Motoring forward

Industrial Support Services | 21/03/2024
Murray International Trust

Business as usual ahead of manager’s retirement

Investment trusts | 21/03/2024
The Pebble Group

Positioned to benefit from re-emerging confidence

Media | 21/03/2024
Braemar

Diversification paying dividends

Industrial Support Services | 20/03/2024
Boku

Making the complex simple for global merchants

Technology | 20/03/2024
Tinexta

Strongest year since FY18

Technology | 20/03/2024
IRLAB Therapeutics

Mesdopetam’s potential highlighted in PD-psychosis

Pharmaceuticals & healthcare | 20/03/2024
Newron Pharmaceuticals

Evenamide set for a pivotal year

Pharmaceuticals & healthcare | 20/03/2024
The Biotech Growth Trust

Onwards and upwards for performance recovery

Investment trusts | 20/03/2024
Team Internet Group

Growth and returns, acquisition bolsters outlook

Technology | 19/03/2024
OPAP

A good end to FY23

Travel & Leisure | 19/03/2024
OSE Immunotherapeutics

One step closer to key data readouts

Pharmaceuticals & healthcare | 19/03/2024
Wheaton Precious Metals

Celebrating the Ides of March

Mining | 18/03/2024
Borussia Dortmund

Progressing nicely

Travel & Leisure | 18/03/2024
SIGA Technologies

Onwards and upwards with strong FY23

Pharmaceuticals & healthcare | 18/03/2024
EML Payments

Sale of Sentenial agreed

Technology | 18/03/2024
Newron Pharmaceuticals

Operational flexibility with new/updated financing

Pharmaceuticals & healthcare | 15/03/2024
musicMagpie

Focus on profits and cash in FY23

Consumer Support Services | 15/03/2024
Foresight Solar Fund

Optimising capital allocation

Investment trusts | 14/03/2024
BlackRock Latin American Inv. Trust

Worthy allocation as part of a global portfolio

Investment trusts | 14/03/2024
Zalaris

Simplifying HR and payroll solutions

Technology | 13/03/2024
Centaur Media

MAP23 plan delivers a higher-quality business

Media | 13/03/2024
4imprint Group

Continued market share gains

Media | 13/03/2024
Mendus

Stars align for CADENCE combination trial

Pharmaceuticals & healthcare | 13/03/2024
Nanoco Group

Mechanisms for shareholder returns confirmed

Technology | 12/03/2024
Nichols

Juicy profits and cash generation

Consumer staples | 12/03/2024
Inchcape

Acceleration in FY23 but more cautious FY24

Automotive Retailers | 12/03/2024
Basilea Pharmaceutica

Strong Cresemba traction triggers milestone payment

Pharmaceuticals & healthcare | 11/03/2024
Wheaton Precious Metals

Putting WPM onto GMT

Mining | 11/03/2024
Dar Global

Demand underpins high-end branded offering

Property | 11/03/2024
1Spatial

SaaS applications to build on Enterprise strength

Technology | 11/03/2024
JDC Group

2024 could turn out to be a very strong year

Financials | 11/03/2024
Informa

FY24 off to a good start

Media | 11/03/2024
Melrose Industries

Continued outperformance

General Industrials | 08/03/2024
CoinShares International

Bli utdelningsbetalare

Financials | 08/03/2024
abrdn UK Smaller Companies Growth Trust

Relative performance getting back on track

Investment trusts | 08/03/2024
Ultimovacs

UV1 hits transitory roadblock with INITIUM top-line

Pharmaceuticals & healthcare | 07/03/2024
Kendrion

Higher visibility on realising FY25 targets

General Industrials | 07/03/2024
KEFI Gold and Copper

The penultimate piece of the puzzle

Mining | 07/03/2024
Capita Group

Capitalising on a more streamlined business

General Industrials | 07/03/2024
International Public Partnerships

Capital markets day

Investment trusts | 06/03/2024

Marked progress on issue resolution

Media | 06/03/2024
HELLENiQ ENERGY

Dividend shows confidence in future

Oil & gas | 05/03/2024
NatWest Group

Time for a re-rating?

Financials | 05/03/2024
Oryzon Genomics

Approaching a period of inflection

Pharmaceuticals & healthcare | 05/03/2024
CoinShares International

Becoming a dividend payer

Financials | 05/03/2024
Primary Health Properties

Stability with income growth

Property | 05/03/2024
EML Payments

Looking to a brighter future

Technology | 05/03/2024
AFT Pharmaceuticals

Poised for international market expansion

Pharmaceuticals & healthcare | 05/03/2024
Borussia Dortmund

A more normal schedule

Travel & Leisure | 05/03/2024
Creo Medical

MicroBlate Flex progresses with first robotics use

Pharmaceuticals & healthcare | 04/03/2024
Ultimovacs

Peer-reviewed publication reiterates UV1’s potential

Pharmaceuticals & healthcare | 04/03/2024
abrdn Private Equity Opportunities Trust

Returns and buyback help narrow the discount

Investment trusts | 04/03/2024
UIL

Long-term focus, avoiding short-term noise

Investment trusts | 04/03/2024
AAC Clyde Space

Strong order backlog underpins growth prospects

Aerospace & Defence | 04/03/2024
AGBA

US$5m placement at a premium

Technology | 04/03/2024
MGI - Media and Games Invest

Back on a growth track

Technology | 04/03/2024
4iG

Record FY23 results; transformation plan underway

Technology | 04/03/2024
Regional REIT

Lancing the boil?

Property | 01/03/2024
Scandic Hotels Group

Tender indeed is the North

Travel & Leisure | 01/03/2024
Dar Global

Initial FY23 results exceed revised guidance

Property | 01/03/2024
SenSen Networks

Clear path to sustainable cash generation

Technology | 01/03/2024
Nano Dimension

Share buyback underway

Technology | 29/02/2024
Good Life Plus

Welcome to the Goodlife!

Travel & Leisure | 29/02/2024
S&U

Impairments drag FY24 PBT, moderation in FY25

Financials | 29/02/2024
The Law Debenture Corporation

One plus one equals three

Investment trusts | 29/02/2024
Freelancer

Primed for margin expansion

Technology | 29/02/2024
Actinogen Medical

Pressing forward with Xanamem

Pharmaceuticals & healthcare | 29/02/2024